INSP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inspire Medical Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for alleged violations of federal securities laws during the specified class period [1][2]. Group 1: Class Definition - The lawsuit seeks to recover damages for all individuals and entities that purchased Inspire securities between August 6, 2024, and August 4, 2025 [2]. Group 2: Case Details - The Complaint alleges that Defendants made materially false and misleading statements regarding the market demand for Inspire V, claiming it was stronger than it actually was [3]. - It is also alleged that the Company failed to take necessary steps for a successful launch of Inspire V, leading to misleading statements about the Company's readiness [3]. Group 3: Next Steps - Investors who suffered losses in Inspire have until January 5, 2026, to request to be appointed as lead plaintiff in the case [4]. Group 4: Legal Representation - The law firm representing the investors operates on a contingency fee basis, meaning they will only collect fees if the case is successful [5]. Group 5: Firm Background - Bronstein, Gewirtz & Grossman, LLC is a nationally recognized law firm that has recovered hundreds of millions of dollars for investors in securities fraud class actions [6].